Evidence map›Paper›PMID 39249620›Full record

ArticleMycopathologia2024

Direct 16S/ITS rRNA Gene PCR Followed by Sanger Sequencing for Detection of Mycetoma Causative Agents in Dakar, Senegal: A Pilot Study Among Patients with Mycetoma Attending Aristide Le Dantec University Hospital.

Khadim Diongue, Jean-Noël Dione, Abdoulaye Diop, Jihane Kabtani, Mamadou Alpha Diallo, Coralie L'Ollivier, Mame Cheikh Seck, Mouhamadou Ndiaye, Aida Sadikh Badiane, Daouda Ndiaye and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Medical mycology case reports · 2025
    Article
  3. The development of a multiplex recombinase polymerase amplification reaction to detect the most common causative agents of eumycetoma.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Khadim DiongueLaboratory of Parasitology and Mycology, Aristide Le Dantec University Hospital, 3001, Dakar, Senegal. khadimase@gmail.com.ORCID http://orcid.org/0000-0002-7033-1169
Jean-Noël DioneIHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.
Abdoulaye DiopUnité de Formation Et de Recherche en Science de La Santé de L'université Assane Seck de Ziguinchor BP 523, Ziguinchor, Senegal.
Jihane KabtaniIHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.
Mamadou Alpha DialloService of Parasitology-Mycology, Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University of Dakar, 10700, Dakar, Senegal.
Coralie L'OllivierIHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.
Mame Cheikh SeckLaboratory of Parasitology and Mycology, Aristide Le Dantec University Hospital, 3001, Dakar, Senegal.
Mouhamadou NdiayeLaboratory of Parasitology and Mycology, Aristide Le Dantec University Hospital, 3001, Dakar, Senegal.
Aida Sadikh BadianeLaboratory of Parasitology and Mycology, Aristide Le Dantec University Hospital, 3001, Dakar, Senegal.
Daouda NdiayeLaboratory of Parasitology and Mycology, Aristide Le Dantec University Hospital, 3001, Dakar, Senegal.
Stéphane RanqueIHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.ORCID https://orcid.org/0000-0003-3293-5276

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycetoma can be caused either by fungi or aerobic Actinomycetes. A precise identification of the causal agents is critical for the therapeutic outcome. Thus, this study aimed to identify the pathogens of mycetoma using 16S/ITS rRNA gene polymerase chain reaction (PCR) followed by Sanger sequencing directly on grains. In sum, 32 samples including 15 black grains, 12 red grains, and five white/yellow grains collected from patients with mycetoma at the Aristide Le Dantec University Hospital in Dakar, Senegal, between October 2014 and September 2020 were submitted to PCR/sequencing. For black grain eumycetoma, the ITS rRNA region was targeted. Similarly, the 16S rRNA gene was targeted for red grain actinomycetoma. These two regions were targeted in parallel for white/yellow grains, which could be of either bacterial or fungal origin. The age of the patients ranged from 14 to 72 years with a mean age of 36 ± 14 years. Thirteen (86%) of the 15 samples with black grains, were successfully sequenced with only one established eumycetoma pathogen, Madurella mycetomatis identified in 11 (73%). Cladosporium sphaerospermum was identified in one sample. For the 16S rRNA sequencing of red grains, a 58.3% (7/12) success rate was obtained with Actinomadura pelletieri identified in six samples. Among the five samples sequenced twice, the 16S rRNA allowed us to identify the causative agent in 2 cases, A. madurae in one, and A. geliboluensis in the other. The ITS rRNA identified 3 fungi, of which none was a mycetoma agent. Overall, direct 16S/ITS rRNA sequencing of the grains for detecting and identifying mycetoma pathogens was successful in 59.4% of cases. Fungi, led by M. mycetomatis, were the predominant pathogens identified. Two probable new mycetoma agents, C. sphaerospermum, and A. geliboluensis were identified and both deserve to be confirmed in further studies.

Indexed as

Hospitals, UniversityMycetomaPolymerase Chain ReactionRNA, Ribosomal, 16SActinobacteriaAdolescentAdultAgedDNA, FungalDNA, Ribosomal SpacerFemaleFungiHumansMadurellaMaleMiddle AgedDNA, FungalDNA, Ribosomal SpacerRNA, Ribosomal, 16S16SITSMycetoma causative agentPCR sequencingSenegal

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.